Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

10/08/2018 07:00

Aug 10 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2018        Jun 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             3.71                3.38              16.70     
                 (+10.0 pct)         (-0.4 pct)        (+0.6 pct)   
  Operating     loss 141 mln        loss 698 mln      loss 520 mln  
  Recurring        558 mln          loss 577 mln      loss 700 mln  
  Net              385 mln          loss 604 mln        loss 1.16   
  EPS             9.25 yen         loss 14.51 yen    loss 27.79 yen 
  Ann Div                                NIL                        
  -Q2 div                                NIL                        
  -Q4 div                                NIL                        
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T